These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 34757660)

  • 21. Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer's disease.
    McKenzie AT; Moyon S; Wang M; Katsyv I; Song WM; Zhou X; Dammer EB; Duong DM; Aaker J; Zhao Y; Beckmann N; Wang P; Zhu J; Lah JJ; Seyfried NT; Levey AI; Katsel P; Haroutunian V; Schadt EE; Popko B; Casaccia P; Zhang B
    Mol Neurodegener; 2017 Nov; 12(1):82. PubMed ID: 29110684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
    Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
    BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease.
    Li HD; Funk CC; McFarland K; Dammer EB; Allen M; Carrasquillo MM; Levites Y; Chakrabarty P; Burgess JD; Wang X; Dickson D; Seyfried NT; Duong DM; Lah JJ; Younkin SG; Levey AI; Omenn GS; Ertekin-Taner N; Golde TE; Price ND
    Alzheimers Dement; 2021 Jun; 17(6):984-1004. PubMed ID: 33480174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism.
    Borkowski K; Seyfried NT; Arnold M; Lah JJ; Levey AI; Hales CM; Dammer EB; Blach C; Louie G; Kaddurah-Daouk R; Newman JW
    Sci Rep; 2023 Aug; 13(1):13752. PubMed ID: 37612324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis.
    Bayraktar A; Lam S; Altay O; Li X; Yuan M; Zhang C; Arif M; Turkez H; Uhlén M; Shoaie S; Mardinoglu A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.
    Talwar P; Silla Y; Grover S; Gupta M; Agarwal R; Kushwaha S; Kukreti R
    BMC Genomics; 2014 Mar; 15(1):199. PubMed ID: 24628925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative Metabolomic Characterization Reveals the Mediating Effect of
    Zhu G; Guo M; Zhao J; Zhang H; Wang G; Chen W
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer's Disease in the Transgenic CRND8 Mice.
    Tang Z; Liu L; Li Y; Dong J; Li M; Huang J; Lin S; Cai Z
    Curr Alzheimer Res; 2016; 13(7):764-76. PubMed ID: 26825095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer's Disease.
    François M; Karpe AV; Liu JW; Beale DJ; Hor M; Hecker J; Faunt J; Maddison J; Johns S; Doecke JD; Rose S; Leifert WR
    Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites.
    Navas-Carrillo D; Rivera-Caravaca JM; Sampedro-Andrada A; Orenes-Piñero E
    Crit Rev Clin Lab Sci; 2021 May; 58(3):167-179. PubMed ID: 33137264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay between Alzheimer's disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice.
    Liu X; Wang W; Chen HL; Zhang HY; Zhang NX
    Acta Pharmacol Sin; 2019 Oct; 40(10):1259-1268. PubMed ID: 31089202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
    Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
    J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.
    Badhwar A; McFall GP; Sapkota S; Black SE; Chertkow H; Duchesne S; Masellis M; Li L; Dixon RA; Bellec P
    Brain; 2020 May; 143(5):1315-1331. PubMed ID: 31891371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted metabolomics and medication classification data from participants in the ADNI1 cohort.
    St John-Williams L; Blach C; Toledo JB; Rotroff DM; Kim S; Klavins K; Baillie R; Han X; Mahmoudiandehkordi S; Jack J; Massaro TJ; Lucas JE; Louie G; Motsinger-Reif AA; Risacher SL; ; ; Saykin AJ; Kastenmüller G; Arnold M; Koal T; Moseley MA; Mangravite LM; Peters MA; Tenenbaum JD; Thompson JW; Kaddurah-Daouk R
    Sci Data; 2017 Oct; 4():170140. PubMed ID: 29039849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the application of metabolomics to Alzheimer's Disease.
    Trushina E; Mielke MM
    Biochim Biophys Acta; 2014 Aug; 1842(8):1232-9. PubMed ID: 23816564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated metabolomics and transcriptomics reveal the neuroprotective effect of nervonic acid on LPS-induced AD model mice.
    Wang X; Li Z; Li X; Liu X; YingMao ; Cao F; Zhu X; Zhang J
    Biochem Pharmacol; 2023 Mar; 209():115411. PubMed ID: 36639003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.
    Kalecký K; German DC; Montillo AA; Bottiglieri T
    J Alzheimers Dis; 2022; 86(4):1875-1895. PubMed ID: 35253754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease.
    Zhang Q; Ma C; Gearing M; Wang PG; Chin LS; Li L
    Acta Neuropathol Commun; 2018 Mar; 6(1):19. PubMed ID: 29490708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.